Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00978575 | Iron Substitution After Upper Gastro-Intestinal Bleeding | ||
| NCT05460234 | RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients | ||
| NCT05766839 | Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels | ||
| NCT04903717 | Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists | ||
| NCT02221752 | Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health | ||
| NCT00882414 | Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD) | ||
| NCT06434025 | IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency | ||
| NCT04938635 | Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia | ||
| NCT01975272 | The Use of Iron Therapy for Patients With Anemia After Caesarean Section | ||
| NCT05524467 | Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients | ||
| NCT01288651 | Iron Deficiency In Pulmonary Hypertension | ||
| NCT01324752 | A Drug-Drug Interaction Study of Losartan and PA21 | ||
| NCT02232906 | Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD) | ||
| NCT04616092 | Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery | ||
| NCT02033317 | An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis | ||
| NCT01438359 | A Drug-Drug Interaction Study of Furosemide and PA21 | ||
| NCT02846896 | The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland | ||
| NCT03010072 | The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum | ||
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) | ||
| NCT05389826 | mHealth for Phosphorus Management in CKD. | ||
| NCT04806048 | Feasibility of Implementation of Recommended Standards in Patients With Heart Failure | ||
| NCT05034250 | Iron Status in Female Infertility and Recurrent Miscarriage | ||
| NCT01394562 | Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure | ||
| NCT05625542 | Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients | ||
| NCT03769441 | Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation | ||
| NCT00810004 | Maintenance Treatment of Iron Deficiency in IBD Patients | ||
| NCT01820949 | Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients | ||
| NCT05885737 | Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus | ||
| NCT01110356 | Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age | ||
| NCT01810939 | A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) | ||
| NCT04510792 | IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors | ||
| NCT05077436 | Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects | ||
| NCT01324128 | A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients | ||
| NCT00824460 | Study of Phosphate Levels in Patients With Chronic Kidney Disease | ||
| NCT05514951 | Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment | ||
| NCT03644264 | PA21 Safety and Efficacy in Adult Chinese Subjects | ||
| NCT01513369 | Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency | ||
| NCT01477424 | A Drug-Drug Interaction Study of Warfarin and PA21 | ||
| NCT00810030 | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR | ||
| NCT00706667 | Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery | ||
| NCT04364269 | Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia | ||
| NCT05415969 | CKD-aP Among Adults on Dialysis in Switzerland | ||
| NCT05861492 | FDDA Utilization Study (FDDAU) | ||
| NCT01245777 | Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy | ||
| NCT01464190 | A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients | ||
| NCT00520780 | Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) | ||
| NCT03781089 | Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients | ||
| NCT03888066 | Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND) | ||
| NCT04864795 | Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia | ||
| NCT01100879 | Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy |
